Enhanced Genomics, a biotechnology company, has announced a strategic partnership with The ALBORADA Drug Discovery Institute at the University of Cambridge.
OutSee has announced it has secured £1.8M in seed funding, led by Ahren Innovation Capital and with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures.
Trelleborg inaugurates its facility expansion in Malta. The €14 million investment in cleanrooms & equipment aims to support the life sciences and semiconductor manufacturing industries.
PCI Pharma Services will use the BIO International Convention, 16-19th June in Boston, as a platform to introduce its new purpose-built facility for large-scale sterile fill-finish operations at its campus in nearby Bedford, NH.
Shilpa Biocare, a fully-owned subsidiary of Shilpa Medicare, announces ahead of BIO Boston that it has secured a Europe-wide commercial supply agreement with Orion Corporation for Recombinant Human Albumin.
TekniPlex Healthcare, which utilises advanced materials science expertise to help deliver better patient outcomes, has commenced production activities at its new 200,000-square-foot facility in Madison, Wisconsin.
XL-protein has announced that it has entered into a worldwide License, Development and Commercialisation Agreement with Grifols for a long-acting biopharmaceutical product.
Tagomics, a biomarker discovery and diagnostics company, has announced it has been awarded £860k Innovate UK funding as part of the Biomedical Catalyst programme for the testing and development of innovative healthcare solutions from Innovate UK.
Brenntag has announced the acquisition of mcePharma. The acquisition and additional investments in the site of mcePharma will "strengthen" Brenntag’s capabilities across the pharma and biopharma value chain.
Medicines Discovery Catapult (MDC) and the Francis Crick Institute have announced a new strategic partnership to support the delivery of KQ Labs, a national accelerator for data-driven health science start-ups.
